1Czock D, Aisenpreis U, Rasche FM, et al. Pharmacokinetics and pharmacodynamics of lispro- insulin in hemodialysis patients with diabetes mellitus[J] . Int J Clin Pharmacol Ther , 2003,41(10) : 492.
3Edelman SV,Morello CM. Strategies for insulin therapy in type 2 diabetes[J]. South Med J,2005,98(3):363.
4Jermendy G. Evidence based therapy with insulin in diabetic patients[J ]. Orv Hetil,2005,146(8) :341.
5Garg SK, Ellis SL, Ulrich H. Insulin glulisine: a new rapid - acting insulin analogue for the treatment of dia- betes[J ]. Exepert Opin Pharmacother, 2005,6(4) : 643.
7Garg SK, Rosenstock J. Optimized basel - lolus insulin regimens in type Ⅰ diabetes: insulin glulisine versus regular human insulin un combination with basal insulin glargine [ J ]. Endocr Pract, 2005, 11 (2) : 145.
8Lepore G,Dodesini AR,Nosari I,et al. Effect of continuous subcutaneous insulin infusion vs multiple daily insulin injection with glargine as basal insulin: an open parallel long- term study[J] . Diabetes Nutr Metab, 2004, 17(2) :84.
9Raslova K, Bogoev M, Raz I, et al. Insulin detemir and insulin aspart: a promising basal - bolus regimen for type 2 diabetes[J] .Diabetes Res Clin Pract, 2004, 66(2) : 193.
10Bott S,Tusek C,Jacobsen LV,et al. Insulin determir understeady- state conditions: no accumulation and con- stant metabolic effect over time with twice daily administration in subjects with type Ⅰ diabetes[J ]. Diabel Med , 2006,23(5) : 522.
5U.K.prospective diabetes study 16.Overview of 6 years' therapy of type H diabetes:a progressive disease.U.K.Prospective Diabetes Study Group[J].Diabets,1995,44 (11):1249-1258.
6FONSECA V,BELL DS,BERGERS,et al.A comparison of bedtime insulin glargine with bedtime neutral protamine hagedorn inlusinin patients with type 2 diabetes;subgroup analysis of patients taking once-daily insulin in a multicenter,randomized,parallel group study[J].Am J Med Sci,2004,328 (5):274-280.
7RIDDLE MC,ROSENSTOCK J,GERICH J.Insulin Glargine 4002 Study Investigators.The treat-to-target trial:randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients[J].Diabetes Care,2003,26 (11):3080-3086.
9Garg SK,Rosentock J. Optimized basel-lolus insulin regimens in type l diabetes: insulin glulisine versus regular human insulin un combination with basal insulin glargine [ J ]. Endocr Pract, 2005,11 (2) : 145.
